Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVT Chemotherapy in Metastatic Melanoma
NCT00885534Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2009
- Primary completion
- Oct 2013
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Cisplatin micelle injection (HA132), vinblastine and temozolomide in melanoma, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Overall Response to CVT Chemotherapy at 2 years. Started Apr 2009; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)vinblastinetemozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00885534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885534.